Journal article
Pituitary production of prolactin and prolactin-suppressing drugs
Lupus, Vol.10(10), pp.660-664
10/2001
DOI: 10.1191/096120301717164886
PMID: 11721691
Abstract
Prolactin secretion from the anterior pituitary is mediated via dopaminergic pathways. Any process that alters dopamine production or transport in the central nervous system may lead to hyperprolactinemia. Most cases of hyperprolactinemia are due to prolactin secreting pituitary tumors or to medications which alter dopamine production. Prolactinomas cause amenorrhea, galactorrhea and infertility in women and impotence and neurological deficits in men. Dopamine receptor agonists are the mainstay of therapy for hyperprolactinemia as they rapidly lower serum prolactin and cause tumor shrinkage. In this paper we review the regulation of prolactin secretion, the clinical features and causes of hyperprolactinemia, and the use of dopamine agonists.
Details
- Title: Subtitle
- Pituitary production of prolactin and prolactin-suppressing drugs
- Creators
- M J Tansey - Department of Pediatrics, University of Iowa, Iowa City, Iowa, USAJ A Schlechte - Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA; Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Lupus, Vol.10(10), pp.660-664
- Publisher
- Sage Publications; Thousand Oaks, CA
- DOI
- 10.1191/096120301717164886
- PMID
- 11721691
- ISSN
- 0961-2033
- eISSN
- 1477-0962
- Language
- English
- Date published
- 10/2001
- Academic Unit
- Endocrinology and Diabetes; Stead Family Department of Pediatrics; Fraternal Order of Eagles Diabetes Research Center; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984093482302771
Metrics
20 Record Views